News
-
-
PRESS RELEASE
Financial results Q2 2026 – Strong first half-year with profitable growth – Guidance confirmed – New partnerships formed
OHB SE reports strong first half-year financial results for Q2 2026, confirming guidance and forming new partnerships. Internationalization strategy advances with milestones -
REGULATED PRESS RELEASE
EURAZEO ENTERS INTO EXCLUSIVE DISCUSSIONS WITH PARTNERS GROUP REGARDING THE CONTEMPLATED SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT
Eurazeo enters exclusive discussions with Partners Group for the sale of its stake in Aroma-Zone and reinvestment. The proposed transaction aims to support Aroma-Zone's next phase of development and international expansion -
-
PRESS RELEASE
Leifheit AG publishes figures for the first half of 2026 and lays the foundation for enhanced competitiveness and profitability with its FOCUS performance program
Leifheit AG reports first half of 2026 results, announces FOCUS performance program for enhanced competitiveness & profitability. Turnover EUR 116.3 million, Group EBIT -2.7 million -
-
PRESS RELEASE
Henkel delivers strong sales and earnings performance in the first half and upgrades top-line expectations for 2026
Henkel delivers strong sales and earnings performance in the first half of 2026, upgrades top-line expectations for 2026. Group sales reach 10.3 billion euros with 3.2% organic growth. Adhesive Technologies sees 4.5% organic sales growth -
-
PRESS RELEASE
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases
Evotec SE and Odyssey Therapeutics collaborate on AI-enabled R&D for autoimmune and inflammatory diseases, aiming to discover new treatments. Collaboration combines expertise and technology to accelerate drug discovery -
